Electromed (ELMD) traded up 0.95 % during a 24 hours period ending at 09:03 AM Central Europe on Tuesday 27th. One Electromed stock can currently be bought for about USD 26.62 on popular exchanges. Current supply of Electromed stocks is 8.3 mn. Electromed has a current market capitalization of USD 220.4 mn and approximately USD 1.1 mn worth of Electromed was traded on exchanges in the last 24 hours. Since last month end, Electromed has traded -5.5 % down. Simple moving average of last 200 days is at USD 31.31. The highest price of past 52 weeks was recorded at USD 47.4 on 07/07/2026. 52 weeks low was at USD 23.01 on 03/18/2026.

Here is how related stocks have performed in the past 24 hours:

  • Techtarget (TTGT) traded up 2.7 % and now trades at USD 3.8. Current market capitalisation for Techtarget is USD 263.3 mn.

  • Fact Ii Acquisition (FACT) traded flat 0 % and now trades at USD 10.76. Fact Ii Acquisition has a market capitalisation of USD 261.7 mn. Fact Ii Acquisition has a current price to earnings ratio of 67.78.

  • Blend Labs (BLND) traded down -0.85 % and now trades at USD 1.16. Blend Labs has a market capitalisation of USD 263.7 mn.

  • Thredup (TDUP) traded down -0.5 % and now trades at USD 1.99. Thredup has a market capitalisation of USD 262.7 mn.

  • American Realty Investors (ARL) traded down -2.52 % and now trades at USD 15.89. Current market capitalisation for American Realty Investors is USD 263.3 mn. American Realty Investors has a current price to earnings ratio of 31.74.

About Electromed

Electromed, Inc. is a health care equipment and supplies company that specializes in manufacturing, marketing, and selling products for airway clearance therapy for patients with compromised pulmonary function. The company’s proprietary system generates High Frequency Chest Wall Oscillation, a technique for airway clearance therapy also known as High Frequency Chest Compression. Electromed, Inc.’s mission is to revolutionize the way patients with chronic obstructive pulmonary diseases (COPD) and other respiratory issues are treated by providing innovative solutions that improve their quality of life.